In a study of children with autoimmune diseases, CHAQ scores were significantly correlated with ROM measures of elbow extension and shoulder flexion while eating; and wrist extension while dressing.
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Clinically Significant Differences
Two observational studies examined changes in CHAQ disability index for children with juvenile arthritis. 7, 8 Changes in score for improvement were small relative to changes in score for those that showed deterioration:
• Improvement was indicated by a median change in CHAQ disability score of -0.13 and -0.25 in the two studies
• A median change in score of +0.75 and +0.36 in the respective studies was shown in children whose condition deteriorated
Randomized Trial of Drug Treatments
The CHAQ was part of an endpoint measurement in one randomized clinical trial in children receiving etanercept to treat polyarticular juvenile rheumatoid arthritis.
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• A response was defined when three of six core measures of disease activity improved by 30%, and no more than one indicator worsened by 30%.
• A 30% change in the CHAQ score was required for classification as improvement or deterioration.
• Fifty-one patients were enrolled in the double-blind study.
• Whereas median CHAQ scores improved 54% from baseline to study end in patients receiving etanercept, no change was observed in patients receiving placebo (p<0.01).
• In an FDA review of the trial, the FDA did not identify any issues related to the CHAQ.
With its excellent psychometric properties, the CHAQ appears valuable for measuring disability and functional status in populations for which it was developed and validated, namely juvenile rheumatoid arthritis.
Because it can be administered in many different languages and given to children of all ages, the CHAQ has a large potential for use in both clinical and research settings.
Although the CHAQ seems to correlate with several joint range of motion measurements and scales, there is still concern regarding the sensitivity of these other instruments.
Additional research is needed to determine the instrument's sensitivity in assessing change associated with use of therapies in non-arthritic populations.
Future studies should be undertaken to provide empirical evidence of its reliability in populations for which the CHAQ has not been validated. There have been relatively few observational studies using the CHAQ; most of these studies were descriptive and uncontrolled in design. INTRODUCTION Historically, assessment of the health-related quality of life (HRQL) of children has received considerably less attention than the HRQL of adults.
1 Few pediatric HRQL instruments have been developed and validated.
HRQL instruments used in adults, but not validated in children, typically do not account for important cognitive, physical, emotional and social development issues of children.
Use of adults as proxies may lead to inaccurate assessments of pediatric HRQL.
Therefore, both generic and disease-specific instruments to measure health-related outcomes in children are needed.
ABOUT THE CHAQ
The Childhood Health Assessment Questionnaire (CHAQ) was developed in 1994 as a parent or self-administered instrument for measuring the functional health status of children with juvenile rheumatoid arthritis.
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The CHAQ was adapted from the Stanford Health Assessment Questionnaire (HAQ), a generic tool that has been used extensively to measure HRQL of patients with a wide variety of diseases.
The CHAQ includes both a disability and discomfort index:
• The disability index measures physical functioning, difficulty in performing daily functions, use of special aids and assistance from another person in eight domains. These include dressing, arising, eating, walking, hygiene, reach, grip, and activities.
• The discomfort index is measured by the Pain Visual Analog Scale (VAS) and by Patient Global Assessment of Arthritis.
The CHAQ takes less than 10 minutes to administer.
In contrast to the extensive use of the HAQ in multiple disease populations, the CHAQ has primarily been used in children with arthritic conditions. This study was conducted to systematically examine the use of the CHAQ in measuring functional status of children and young adults with non-arthritic indications, and to assess its sensitivity to effects observed in clinical trials of drug treatments.
A computerized literature search conducted in the MEDLINE database (1966-present) identified English-language publications with the term "Childhood Health Assessment Questionnaire."
Additional searches were conducted to identify the use of the CHAQ in clinical studies of specific juvenile arthropathies for comparisons, including all forms of juvenile rheumatoid arthritis (polyarticular, pauciarticular, and systemic), juvenile spondyloarthropathy, and juvenile idiopathic inflammatory myopathies, such as juvenile dermatomyositis.
The electronic database findings were supplemented by manual searches cross-referenced from bibliographies of the articles retrieved.
Articles were selected for detailed review if they met specific criteria related to the CHAQ's development and use.
The following aspects were examined in the articles selected:
• Study type
• Country
• Patient Population
• Psychometric validity in a specified patient population
• Correlations with objective clinical measures, such as joint range of motion
OVERVIEW
Of 239 abstracts screened from the initial MEDLINE search, 59 studies met criteria for review and were retrieved. In addition to these, 10 articles were obtained via supplemental manual searches.
A summary of the diseases, geographic location, and types of studies for which the CHAQ was used is listed in Table 1 .
The majority of the CHAQ articles were cross-cultural adaptation, validation, and evaluation studies for countries outside the United States. A list of validated language translations and versions of the CHAQ is listed in Table 2 .
The CHAQ has mainly been utilized to measure disability and functional status in patients with rheumatic or musculoskeletal problems, namely various forms of juvenile rheumatoid arthritis, juvenile spondyloarthropathy, spina bifida, juvenile idiopathic inflammatory myopathies, and juvenile onset mixed connective tissue disease. 
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PSYCHOMETRIC PROPERTIES
The CHAQ demonstrates excellent reliability, validity, and parent-child correlations, summarized in Table 3 .
